A Preliminary Study on the Intervention Effect of Virtual Reality Exposure Therapy on Fear of Flying

A Preliminary Study on the Intervention Effect of Virtual Reality Exposure Therapy on Fear of Flying

The goal of this clinical trial is to explore the efficacy of VR exposure intervention in alleviating fear of flying through a randomized controlled study.

Inclusion Criteria:

• The flight anxiety situations questionnaire (FAS) score is no less than 56 points (the critical value is set as two or more standard deviations higher than the average of the normal population);
• Aged between 18 and 65 years old;
• Have normal intelligence and good or corrected vision;
• No family history of any mental illness or other mental disorders other than anxiety disorder;
• Currently not receiving any treatment for phobia, including but not limited to taking psychotropic drugs (unless the dose is stable for more than 3 months, and the subject agrees to continue taking the dose throughout the study);
• Have at least 1 flight experience;

Exclusion Criteria:

• The participant cannot tolerate or adapt to VR stimulation;
• The participant was unable to immerse themselves well in the VR environment;
• Severe physical diseases and physical diseases induced by stimulation, including cardiovascular and respiratory diseases, etc.;
• Have a history of neurological diseases (such as epilepsy, cerebrovascular accident, etc.) or brain trauma or brain surgery;
• The subject suffers from a physical disease and is not in a stable treatment period (such as hyperthyroidism, visual impairment, etc.), resulting in the inability to fully participate in the experimental process;
• Pregnant women.